BioRem Inc. (TSXV:BRM)
3.870
+0.100 (2.65%)
Aug 10, 2026, 3:59 PM EST
BioRem Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 7.19 | 11.5 | 5.21 | 2.29 | 3.78 | 4.47 |
Cash & Short-Term Investments | 7.19 | 11.5 | 5.21 | 2.29 | 3.78 | 4.47 |
Cash Growth | -6.11% | 120.70% | 127.46% | -39.29% | -15.57% | -49.59% |
Accounts Receivable | 19.14 | 15.2 | 14.87 | 14.11 | 12.24 | 10.13 |
Inventory | 2.13 | 1.37 | 2.9 | 0.9 | 0.89 | 0.9 |
Other Current Assets | 4.64 | 2.48 | 1.54 | 2.33 | 0.87 | 0.66 |
Total Current Assets | 33.1 | 30.55 | 24.52 | 19.63 | 17.77 | 16.17 |
Net Property, Plant & Equipment | 1.98 | 1.83 | 2.02 | 1.99 | 1.02 | 1.15 |
Other Long-Term Assets | 0.57 | 1.2 | 1.97 | 2.45 | 1.94 | 1.86 |
Total Assets | 35.64 | 33.58 | 28.51 | 24.08 | 20.73 | 19.17 |
Accounts Payable | 5.6 | 7.95 | 4.02 | 6.14 | 4.71 | 5.07 |
Accrued Expenses | 1.88 | 1.84 | 2.44 | 2.13 | 2.66 | 2.51 |
Short-Term Debt | 0.61 | 0.59 | 0.57 | 0.55 | 1.3 | 1.51 |
Current Portion of Leases | 0.09 | 0.08 | 0.12 | 0.18 | 0.16 | 0.19 |
Unearned Revenue | 6.94 | 4.59 | 6.37 | 4.31 | 2.57 | 3.02 |
Other Current Liabilities | 1.15 | 1.44 | 1.5 | 0.6 | 1.52 | 0.94 |
Total Current Liabilities | 16.26 | 16.49 | 15.02 | 13.89 | 12.92 | 13.23 |
Long-Term Debt | 0.96 | 1.26 | 1.86 | 2.43 | 2.98 | 3.5 |
Long-Term Leases | 0.84 | 0.89 | 1.01 | 1.03 | 0.31 | 0.47 |
Total Long-Term Liabilities | 1.79 | 2.16 | 2.87 | 3.46 | 3.29 | 3.97 |
Total Liabilities | 18.06 | 18.65 | 17.89 | 17.36 | 16.21 | 17.2 |
Common Stock | 5.28 | 5.2 | 5.2 | 5 | 4.91 | 4.91 |
Additional Paid-in Capital | 2.54 | 2.53 | 2.47 | 2.37 | 2.26 | 2.17 |
Accumulated Other Comprehensive Income | 1.76 | 1.34 | 1.83 | 1.27 | 1.45 | 0.6 |
Retained Earnings | 8.01 | 5.86 | 1.13 | -1.92 | -4.1 | -5.71 |
Shareholders' Equity | 17.59 | 14.93 | 10.63 | 6.72 | 4.52 | 1.96 |
Total Liabilities & Equity | 35.64 | 33.58 | 28.51 | 24.08 | 20.73 | 19.17 |
Total Debt | 2.49 | 2.83 | 3.56 | 4.19 | 4.75 | 5.67 |
Net Cash (Debt) | 4.69 | 8.67 | 1.66 | -1.89 | -0.97 | -1.19 |
Net Cash Growth | 3.98% | 423.68% | - | - | - | - |
Net Cash Per Share | 0.25 | 0.47 | 0.09 | -0.11 | -0.06 | -0.03 |
Book Value | 17.59 | 14.93 | 10.63 | 6.72 | 4.52 | 1.96 |
Book Value Per Share | 0.94 | 0.80 | 0.57 | 0.39 | 0.26 | 0.05 |
Tangible Book Value | 17.59 | 14.93 | 10.63 | 6.72 | 4.52 | 1.96 |
Tangible Book Value Per Share | 0.94 | 0.80 | 0.57 | 0.39 | 0.26 | 0.05 |